CN102670569A - Method for preparing absorbable minocyline drug diaphragm - Google Patents
Method for preparing absorbable minocyline drug diaphragm Download PDFInfo
- Publication number
- CN102670569A CN102670569A CN2012101358842A CN201210135884A CN102670569A CN 102670569 A CN102670569 A CN 102670569A CN 2012101358842 A CN2012101358842 A CN 2012101358842A CN 201210135884 A CN201210135884 A CN 201210135884A CN 102670569 A CN102670569 A CN 102670569A
- Authority
- CN
- China
- Prior art keywords
- diaphragm
- minocyline
- drug
- minocycline
- absorbable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention relates to a method for preparing an absorbable minocyline drug diaphragm, which comprises the step of operating that 1 hydrochloric acid minocyline powder is dissolved into distilled water to obtain hydrochloric acid minocyline solution; 2 gelatin is added into the hydrochloric acid minocyline solution in water bath at 40 DEG C to be uniformly mechanically stirred away from light; 3 glycerin is further added in the water bath at 40 DEG C to go on to be uniformly stirred and obtain faint yellow viscous liquid; 4 the faint yellow viscous liquid is paved on a plate to be made into a diaphragm in room temperature, and a gel diaphragm which has a thickness of 0.5-0.6mm is obtained after solidifying; and 5 the gel diaphragm is frozen and dried to obtain the absorbable minocyline drug diaphragm. The method for preparing the absorbable minocyline drug diaphragm is simple in operation, excellent in controlling, environmental friendly and high in yield. The method for preparing the absorbable minocyline drug diaphragm is convenient to be applied in clinical, compared with similar products abroad, the absorbable minocyline drug diaphragm has excellent cost performance, and does not have obvious difference in effects of clinical application.
Description
Technical field
The invention belongs to bio-pharmaceutical engineer technology domain, relate to the method for preparing of local application in the clinical oral materia medica.
Background technology
Periodontitis is a kind of by the cause a disease pathological changes of a kind of progressive irreversible destruction periodontal support tissue that dominant microflora causes of periodontal.Its sickness rate is high, and is ascendant trend gradually, and along with the increase at age, its sickness rate also increases gradually.Along with the aging of society, the ratio of periodontal in the clinical outpatient service of stomatology is also increasingly high.Drug therapy is occupied critical role as a kind of important foundation Therapeutic Method of periodontal in the treatment of periodontal disease.The oral systemic administration method that waits often causes the periodontal local drug concentration low, bad complication, and cause certain waste.Therefore,, can overcome the shortcoming that is administered systemically, become the topmost administering mode of present periodontal disease Drug therapy at pathological changes periodontal topical.Using antibacterials in the periodontal disease therapeutic at present mainly is the imidazoles antibacterials, like metronidazole, tinidazole, ornidazole; Tetracyclines.The example hydrochloric acid tetracycline, minocycline etc.The slow release formulation that periodontal uses mainly contains at present; Home-made metronidazole rod (starch fiber carrier), its storage time in periodontal pocket is short; The present domestic use of imported product mainly be the minocycline ointment of commodity Palio by name, its clinical application effect is good, and is easy to operate, but price is more expensive.
Minocycline not only has sensitivity to the dominant microflora of periodontitis, and can suppress the decomposition of connective tissue, suppresses the absorption of bone.Therefore, be a kind of comparatively ideal selection at the local use of periodontitis minocycline preparation.The Drug therapy of periodontitis is occupied bigger clinical technology proportion at China's basic hospital, and therefore, the periodontal topical pharmaceutical formulation of development of new has great demand.
Summary of the invention
In order to solve the more expensive problem of periodontitis Drug therapy Chinese medicine price, the present invention provides a kind of method for preparing of good, absorbability minocycline medicine film that product has good cost performance simple to operate, controlled.
Concrete operations step of the present invention is following:
1. diaphragm-operated method for preparing of absorbability minocycline medicine is characterized in that:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2~0.5 gram
Gelatin 0.5~1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
The preparation manipulation step is following:
(1). 0.2~0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5~1 gram gelatin, water-bath under 40 ℃ of conditions of temperature, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, water-bath under 40 ℃ of conditions of temperature continues to stir, and gets light yellow viscous liquid;
(4). with light yellow viscous liquid, bed board system film at room temperature solidifies that to obtain thickness be the gel diaphragm of 0.5~0.6mm;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge.
Useful technique effect of the present invention is embodied in the following aspects:
1, method for preparing of the present invention is simple to operate, and is controlled good, environmental friendliness, and output is high;
2, method for preparing clinical practice of the present invention is convenient, belongs to the non-invasive therapy technology, is easy to promote;
3, medicine diaphragm of the present invention will soften in vivo, have good fitness with the periodontal pocket environment;
4, the new material of the present invention's acquisition is compared with external like product, has good cost performance, the clinical application effect no significant difference.
The specific embodiment
Below in conjunction with embodiment the present invention is done to describe further.
Embodiment 1:
The diaphragm-operated method for preparing of absorbability minocycline medicine comprises following operating procedure:
Raw materials used with the amount as follows:
Minocycline hydrochloride (purity 99%, Wuhan Yuancheng Technology Development Co., Ltd., China) 0.5 gram
Gelatin (Sigm-Aldrich company, the U.S.) 1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
(1). 0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 1 gram gelatin, 40 ℃ of water-baths, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, 40 ℃ of water-baths continue to stir, and obtain light yellow viscous liquid;
(4). with light yellow viscous liquid, at room temperature bed board system film solidifies the gel diaphragm that obtains the about 0.5mm of thickness;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline medicine diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge;
(6) C
60Sterilization, subsequent use.
Illustrate the clinical practice of absorbability minocycline medicine film below, range of application of the present invention is not limited thereto.
Give an example 1: be applied to the treatment of chronic periodontitis
Method for using:
Behind the periodontitis cacodontia cleaning tooth body, at a distance from wetting, dry up gingival sulcus.Above-mentioned minocycline diaphragm is placed in the periodontal pocket.
Give an example 2: be applied to the treatment of acute pericoronitis of the wisdom tooth
Acute pericoronitis of the wisdom tooth, at first after the flushing of conventional 3% hydrogen peroxide, the tooth body is placed into above-mentioned minocycline diaphragm in the hat week bag at a distance from wetting, dry up gingival sulcus.
Embodiment 2:
The method for preparing of absorbability minocycline medicine film comprises following operating procedure:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2 gram
Gelatin 0.5 gram
2 milliliters of glycerol
8 milliliters of distilled water;
(1). 0.2 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5 gram gelatin, 40 ℃ of water-baths, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, 40 ℃ of water-baths continue to stir, and obtain light yellow viscous liquid;
(4). with light yellow viscous liquid, at room temperature bed board system film solidifies the gel diaphragm that obtains the about 0.5mm of thickness;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline medicine diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge;
(6) C
60Sterilization, subsequent use.
Claims (1)
1. diaphragm-operated method for preparing of absorbability minocycline medicine is characterized in that:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2~0.5 gram
Gelatin 0.5~1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
The preparation manipulation step is following:
(1). 0.2~0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5~1 gram gelatin, water-bath under 40 ℃ of conditions of temperature, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, water-bath under 40 ℃ of conditions of temperature continues to stir, and gets light yellow viscous liquid;
(4). with light yellow viscous liquid, bed board system film at room temperature solidifies that to obtain thickness be the gel diaphragm of 0.5~0.6mm;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101358842A CN102670569A (en) | 2012-05-04 | 2012-05-04 | Method for preparing absorbable minocyline drug diaphragm |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101358842A CN102670569A (en) | 2012-05-04 | 2012-05-04 | Method for preparing absorbable minocyline drug diaphragm |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102670569A true CN102670569A (en) | 2012-09-19 |
Family
ID=46803564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101358842A Pending CN102670569A (en) | 2012-05-04 | 2012-05-04 | Method for preparing absorbable minocyline drug diaphragm |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102670569A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023082A (en) * | 1986-05-18 | 1991-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
-
2012
- 2012-05-04 CN CN2012101358842A patent/CN102670569A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023082A (en) * | 1986-05-18 | 1991-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
Non-Patent Citations (2)
Title |
---|
姜大川等: "新型牙周药剂治疗慢性牙周炎的临床观察", 《安徽医科大学学报》, vol. 45, no. 5, 31 October 2010 (2010-10-31), pages 671 - 672 * |
王姹等: "米诺环素凝胶辅助治疗牙周炎的临床观察", 《安徽医科大学学报》, vol. 47, no. 1, 31 January 2012 (2012-01-31), pages 63 - 66 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105581992A (en) | Preparation method and application of starch/ferulic acid colon-targeted controlled-release carrier matrix tablet | |
CN103193772A (en) | Preparation method and application of substituted aryl propionic berberine ion-pair compound | |
CN111012737A (en) | Flurbiprofen sodium gel and preparation method thereof | |
TW201029651A (en) | Anti-inflammatory compounds and compositions thereof | |
CN102743333A (en) | Levetiracetam oral liquid and preparation method of levetiracetam oral liquid | |
AU642309B2 (en) | Complexes containing S(+) phenyl alkane acids and amino sugars | |
JPS5896036A (en) | Manufacture of novel naphthalene derivative | |
JP4750691B2 (en) | Anti-inflammatory treatment | |
CN101474144A (en) | Tetracaine hydrochloride lipidosome gel and preparation method thereof | |
CN102670569A (en) | Method for preparing absorbable minocyline drug diaphragm | |
CN102579390A (en) | Ibuprofen timing release three-layer tablet drug composition and method for preparing same | |
CN104447770A (en) | Asenapine compound | |
JP2017534635A (en) | Crystalline polymorph of revaprazan hydrochloride and its preparation method | |
CN102283926A (en) | Preparation technology and production method for novel integrated dosage form of liver fire-purging and stomach-regulating pill | |
CN101249063A (en) | Calciparine/sodium salt nano oral preparation and preparation technique thereof | |
CN101978945A (en) | Ibuprofen medicinal composition | |
CN102283937A (en) | Technology for preparing novel integrated dosage form of stomach-clearing powder and production method thereof | |
US20040265299A1 (en) | Oral pharmaceutical formulation containing active carbon and use of the same | |
CN103893767A (en) | Ibuprofen medicine composition with stable quality | |
CN102697703A (en) | Piroxicam gel preparation and preparation method thereof | |
CN118021746B (en) | Preparation method and application of orally disintegrating tablet for treating dental ulcer | |
CN1895269A (en) | Compound iodine oral solution quantitative drops and preparation thereof | |
CN103028095A (en) | Preparation technology and production method of integrated new dosage form of dry ginger and Radix aconiti lateralis preparata decoction | |
CN102283990A (en) | Technology for preparing novel sweet wormwood and turtle shell decoction integrated preparation | |
RU2012111354A (en) | NEW CRYSTALLINE HYDRATES OF FLUORGYCLOSIDES CONTAINING THEIR PHARMACEUTICAL DRUGS AND THEIR USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120919 |